ArticleScience progress2026
Distribution characteristics of dyslipidemia in ABO blood groups in Suburbs of Shanghai, China: A cross-sectional study.
Article in Science progress, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveTo investigate the distribution features of dyslipidemia within the ABO blood group system Suburbs of Shanghai, China.MethodsThis retrospective cross-sectional study analyzed 12,926 sets of blood lipid data associated with the ABO blood group from January 2018 to December 2024 at Tinglin Hospital in Suburbs of Shanghai. We presented the overall prevalence of dyslipidemia across various ABO blood groups with respect to sex and blood lipid indicators.ResultsAmong the 12,926 individuals included in the study, the overall prevalence of dyslipidemia was 53.44%. The prevalence by blood group was 55.59% in type A, 51.82% in type B, 52.49% in type O, and 54.89% in type AB. Across all blood groups, males consistently showed higher dyslipidemia rates than females, and the sex differences were significant in each ABO group (all P < 0.001).ConclusionIn this hospital-based adult population, dyslipidemia was common and crude prevalence differed modestly across ABO blood groups, with type A showing the highest and type B the lowest prevalence. Across all blood groups, prevalence in male was significantly higher than in female (all P < 0.001). After adjustment for age and sex, adjusted odds ratios (aORs) with 95% confidence intervals (95% CIs) indicated higher odds of dyslipidemia for blood group A and lower odds for blood group B compared with group O. However, these comparisons are derived from a retrospective hospital-based dataset and are subject to residual confounding because key lifestyle and clinical factors (e.g., BMI, smoking, comorbidities, and medications) were not available for full adjustment; therefore, the findings should be interpreted as descriptive rather than causal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.